GSK3B and Alzheimer disease: Conditional overexpression of GSK-3β causes neuronal death, hyperphosphorylation of tau protein and cognitive impairments in mice [79], while GSK-3β inhibitors have been found to reverse cognitive deficits in several rodent models of AD [80].